跳至主要内容
临床试验/CTRI/2023/05/052447
CTRI/2023/05/052447尚未招募3 期

Clinical study on shweta pradara w.s.r candida albicans with nagakesar churna and takra

Dr Krutika Mishra1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年5月15日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Relief from candida albicans infection

研究概览

简要总结

Shweta Pradara, commonly characterized as white vaginal discharge, is not a disease but a symptom of so many diseases. It is the white vaginal discharge with intense vulvovaginal pruritus. Therefore I have correlated Shweta Pradara with Candida Albicans infection or Candidiasis. so under this trial, Nagakesar churna will be given to 40 patients with Takra Anupaan as mentioned in Bhava Prakash chikitsa and Yoga Ratnakar in Soma Roga Adhikar.  The trial drug will be given for 15 days with takra as anupana including the menstrual cycle. Follow Up with all the patients will be done every 15 days for 2 cycles. After the trial, the followup will be done after 1 month.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Participant Blinded

入排标准

年龄范围
12.00 Year(s) 至 60.00 Year(s)(—)
性别
Female

入选标准

  • 1 Patients having thick curdy white vaginal discharge 2 Patients having signs and symptoms same as candida albicans infection 3 Age group-
  • 60 yrs 4 Patients diagnosed with Shweta Pradara 5 Patients diagnosed with uncomplicated Candida albicans 6 Patients diagnosed with recurrent and severe Candida albicans.

排除标准

  • 1 Presence of infective organisms other than Candida albicans 2 Positive VDRL, HIV (STDs) 3 Oral contraceptive pills and contraceptive devices 4 Positive pap smear 5 Non-albicans candidiasis 6 Women with uncontrolled diabetes, debilitation, or immunosuppression 7 Uterine tumour or any other growth.

结局指标

主要结局

Relief from candida albicans infection

时间窗: 2 weeks

次要结局

  • Improved immune system(8 weeks)

研究者

发起方
Dr Krutika Mishra
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验